- Credit Type: CPE
- Credit Amount: 1.00
- Cost: $5.00
- Release: Feb 9, 2015
- Expires: Oct 23, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Assistant Professor, Infectious Disease
University of Kentucky College of Medicine
Needs StatementHepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States; approximately 3.2 million persons are chronically infected. Although HCV is not efficiently transmitted sexually, persons at risk for infection through injection drug use might seek care in STD treatment facilities, HIV counseling and testing facilities, correctional facilities, drug treatment facilities, and other public health settings where STD and HIV prevention and control services are available.
ObjectivesUpon Completion of this activity Pharmacist will be able to:
1. Identify the current literature and guidelines used in the treatment of hepatitis C
2. Evaluate laboratory testing, drug interactions, and common adverse events of the antiviral agents
3. Design an appropriate regimen and monitoring plan for hepatitis C therapy
4. Describe emerging investigational therapies for the treatment of hepatitis C
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This application-based activity has been assigned UAN 0022-0000-15-017-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.
Faculty DisclosureTakako Schaninger, MD (Speaker) has no relevant financial relationships with commercial interests.
Takako Schaninger does intend to discuss the off-label use of a product.
No planners have any relevant financial relationships to disclose.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.